New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Adagrasib effective for patients with KRAS G12C-mutant lung cancer and untreated brain metastases

Adagrasib effective for patients with KRAS G12C-mutant lung cancer and untreated brain metastases

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center found the KRAS G12C inhibitor adagrasib sho
World medicine December 05,2023
Adagrasib effective for patients with KRAS G12C-mutant lung cancer and untreated brain metastases

Adagrasib effective for patients with KRAS G12C-mutant lung cancer and untreated brain metastases

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center found the KRAS G12C inhibitor adagrasib sho
World medicine December 05,2023
YAP/TEAD inhibitor VT3989 is well tolerated, shows antitumor activity in advanced mesothelioma and NF2-mutant cancers

YAP/TEAD inhibitor VT3989 is well tolerated, shows antitumor activity in advanced mesothelioma and NF2-mutant cancers

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainThe first-in-class YAP/TEAD inhibitor VT3989 was well tolerated with durable antitumor responses in patients with advan
World medicine December 05,2023
YAP/TEAD inhibitor VT3989 is well tolerated, shows antitumor activity in advanced mesothelioma and NF2-mutant cancers

YAP/TEAD inhibitor VT3989 is well tolerated, shows antitumor activity in advanced mesothelioma and NF2-mutant cancers

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainThe first-in-class YAP/TEAD inhibitor VT3989 was well tolerated with durable antitumor responses in patients with advan
World medicine December 05,2023
Discovery in T-cell research could lead to improved treatment of solid tumors

Discovery in T-cell research could lead to improved treatment of solid tumors

byAgency for Science, Technology and Research (A*STAR), SingaporeCell therapy process for patients with Hepatocellular carcinoma (HCC), a tumor of the liver. Credit: Agency for Science, Technolo
World medicine December 05,2023
Discovery in T-cell research could lead to improved treatment of solid tumors

Discovery in T-cell research could lead to improved treatment of solid tumors

byAgency for Science, Technology and Research (A*STAR), SingaporeCell therapy process for patients with Hepatocellular carcinoma (HCC), a tumor of the liver. Credit: Agency for Science, Technolo
World medicine December 05,2023
T cells can activate themselves to fight tumors

T cells can activate themselves to fight tumors

byUniversity of California - San DiegoT cells are a type of white blood cell and play a central role in the immune response. Credit: National Institute of Allergy and Infectious DiseasesWhen you
World medicine December 05,2023
T cells can activate themselves to fight tumors

T cells can activate themselves to fight tumors

byUniversity of California - San DiegoT cells are a type of white blood cell and play a central role in the immune response. Credit: National Institute of Allergy and Infectious DiseasesWhen you
World medicine December 05,2023
Gamma delta T cells can fight aggressive breast cancer

Gamma delta T cells can fight aggressive breast cancer

byUniversity of FreiburgFluorescence microcopy image of gamma delta T cells (green) attacking cancer cells (blue). To get tot he cancer cells, the immune cells need to navigate through a dense e
World medicine December 05,2023
Gamma delta T cells can fight aggressive breast cancer

Gamma delta T cells can fight aggressive breast cancer

byUniversity of FreiburgFluorescence microcopy image of gamma delta T cells (green) attacking cancer cells (blue). To get tot he cancer cells, the immune cells need to navigate through a dense e
World medicine December 05,2023
T-cell activator offers protection against coronaviruses in immunocompromised cancer patients

T-cell activator offers protection against coronaviruses in immunocompromised cancer patients

by Universitätsklinikum TübingenThe T-cell activator CoVac-1 offers the particularly vulnerable group of immunocompromised individuals sustained protection against coronavirus. Credit: Beate Armbruste
World medicine December 05,2023
T-cell activator offers protection against coronaviruses in immunocompromised cancer patients

T-cell activator offers protection against coronaviruses in immunocompromised cancer patients

by Universitätsklinikum TübingenThe T-cell activator CoVac-1 offers the particularly vulnerable group of immunocompromised individuals sustained protection against coronavirus. Credit: Beate Armbruste
World medicine December 05,2023
tRNA biomarkers for cancer diagnosis and prognosis enabled by new method

tRNA biomarkers for cancer diagnosis and prognosis enabled by new method

by Center for Genomic RegulationCredit: Eva Novoa/Center for Genomic Regulation (CRG)Ribonucleic acid (RNA) molecules are present in all living cells, with different types of RNA having different jobs
World medicine December 05,2023
tRNA biomarkers for cancer diagnosis and prognosis enabled by new method

tRNA biomarkers for cancer diagnosis and prognosis enabled by new method

by Center for Genomic RegulationCredit: Eva Novoa/Center for Genomic Regulation (CRG)Ribonucleic acid (RNA) molecules are present in all living cells, with different types of RNA having different jobs
World medicine December 05,2023
Differential silencing of STAT3 isoforms leads to changes in STAT3 activation

Differential silencing of STAT3 isoforms leads to changes in STAT3 activation

by Impact Journals LLCCytokine expression and cell viability upon mRNA silencing of STAT3 isoforms. Credit: 2023 Shamir et al.A new research paper was published inOncotarget's, titled "
World medicine December 05,2023
Differential silencing of STAT3 isoforms leads to changes in STAT3 activation

Differential silencing of STAT3 isoforms leads to changes in STAT3 activation

by Impact Journals LLCCytokine expression and cell viability upon mRNA silencing of STAT3 isoforms. Credit: 2023 Shamir et al.A new research paper was published inOncotarget's, titled "
World medicine December 05,2023
Catching up with SOLUS: A new diagnostic approach for breast cancer

Catching up with SOLUS: A new diagnostic approach for breast cancer

byCORDISCredit: CordisBreast cancer diagnosis is an area that is constantly evolving, with new innovations emerging to improve patient outcomes. TheSOLUSproject is one such innovativ
World medicine December 05,2023
Catching up with SOLUS: A new diagnostic approach for breast cancer

Catching up with SOLUS: A new diagnostic approach for breast cancer

byCORDISCredit: CordisBreast cancer diagnosis is an area that is constantly evolving, with new innovations emerging to improve patient outcomes. TheSOLUSproject is one such innovativ
World medicine December 05,2023
Selinexor found to increase progression-free survival for endometrial cancer with TP53 mutations

Selinexor found to increase progression-free survival for endometrial cancer with TP53 mutations

by Lori SolomonMaintenance therapy with selinexor provides durable survival benefits for endometrial cancer with TP53 mutations, according to a study presented during the July 2023 session of the Amer
World medicine December 05,2023
Selinexor found to increase progression-free survival for endometrial cancer with TP53 mutations

Selinexor found to increase progression-free survival for endometrial cancer with TP53 mutations

by Lori SolomonMaintenance therapy with selinexor provides durable survival benefits for endometrial cancer with TP53 mutations, according to a study presented during the July 2023 session of the Amer
World medicine December 05,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com